Page 124 - AN-3-1

Advanced Neurology ESUS, atrial fibrillation, and recurrence

14. Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of 21. He J, Jiang Y, Xiao Y, et al. Effect of implantable cardiac
undetermined source: The case for a new clinical construct. monitors on preventing stroke: A systematic review and
Lancet Neurol. 2014;13(4):429-438. meta-analysis of randomized clinical trials. PLoS One.
2023;18(7):e0287318.
doi: 10.1016/S1474-4422(13)70310-7
doi: 10.1371/journal.pone.0287318
15. Ratajczak-Tretel B, Lambert AT, Al-Ani R, et al. Underlying
causes of cryptogenic stroke and TIA in the nordic atrial 22. Kitsiou A, Rogalewski A, Kalyani M, et al. Atrial fibrillation
fibrillation and stroke (NOR-FIB) study-the importance in patients with embolic stroke of undetermined source
of comprehensive clinical evaluation. BMC Neurol. during 3 years of prolonged monitoring with an implantable
2023;23:115. loop recorder. Thromb Haemost. 2021;121(6):826-833.
doi: 10.1186/s12883-023-03155-0 doi: 10.1055/a-1346-2899
16. Noubiap JJ, Agbaedeng TA, Kamtchum-Tatuene J, et al. 23. Ntaios G, Pearce LA, Veltkamp R, et al. Potential
Rhythm monitoring strategies for atrial fibrillation detection embolic sources and outcomes in embolic stroke of
in patients with cryptogenic stroke: A systematic review and undetermined source in the NAVIGATE-ESUS trial. Stroke.
meta-analysis. Int J Cardiol Heart Vasc. 2021;34:100780. 2020;51:1797-1804.
doi: 10.1161/STROKEAHA.119.028669
doi: 10.1016/j.ijcha.2021.100780
24. Kirchhof P, Toennis T, Goette A, et al. Anticoagulation with
17. Kitsiou A, Sagris D, Schäbitz WR, Ntaios G. Validation of
the AF-ESUS score to identify patients with embolic stroke edoxaban in patients with atrial high-rate episodes. N Engl J
Med. 2023;389(13):1167-1179.
of undetermined source and low risk of device-detected
atrial fibrillation. Eur J Intern Med. 2021;89:135-136. doi: 10.1056/NEJMoa2303062
doi: 10.1016/j.ejim.2021.04.003 25. Uhe T, Wasser K, Weber-Krüger M, et al. Intensive heart
rhythm monitoring to decrease ischemic stroke and systemic
18. Ratajczak-Tretel B, Tancin Lambert A, Al-Ani R, et al. Atrial embolism-the Find-AF 2 study-rationale and design. Am
fibrillation in cryptogenic stroke and TIA patients in The Heart J. 2023;265:66-76.
Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study:
Main results. Eur Stroke J. 2023;8(1):148-156. doi: 10.1016/j.ahj.2023.06.016
doi: 10.1177/23969873221123122 26. Grifoni E, Giglio D, Guazzini G, et al. Age-related burden
and characteristics of embolic stroke of undetermined source
19. von Falkenhausen AS, Feil K, Sinner MF, et al. Atrial in the real world clinical practice. J Thromb Thrombolysis.
fibrillation risk assessment after embolic stroke of 2020;49(1):75-85.
undetermined source. Ann Neurol. 2023;93:479-488.
doi: 10.1007/s11239-019-01951-544
doi: 10.1002/ana.26545
27. Perera KS, de Sa Boasquevisque D, Rao-Melacini P, et al.
20. Ntaios G, Perlepe K, Lambrou D, et al. Prevalence and Evaluating rates of recurrent ischemic stroke among young
overlap of potential embolic sources in patients with adults with embolic stroke of undetermined source: The
embolic stroke of undetermined source. J Am Heart Assoc. young ESUS longitudinal cohort study. JAMA Neurol.
2019;8(15):e012858. 2022;79(5):450-458.
doi: 10.1161/JAHA.119.012858 doi: 10.1001/jamaneurol.2022.0048

Volume 3 Issue 1 (2024) 7 https://doi.org/10.36922/an.2287